{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:55:26Z","timestamp":1790610926698,"version":"4.1.0"},"reference-count":31,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fatigue remains a major unresolved issue affecting the quality of life of patients with inflammatory bowel disease (IBD), even during clinical remission. Scalable psychological approaches are needed to support effective fatigue management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim of this study is to evaluate the effectiveness of a multicomponent mobile cognitive behavioral intervention package for fatigue management among patients with IBD in remission and to explore factors associated with engagement with the intervention and its effectiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was an open-label, waitlist-controlled randomized controlled trial. Eligible participants were adults (\u226518 years) diagnosed with Crohn disease or ulcerative colitis who met remission criteria and had at least mild fatigue. Participants were randomized 1:1 using stratified block randomization based on disease type, sex, and baseline fatigue severity. The intervention was a multicomponent mobile intervention package centered on a 7-week cognitive behavioral therapy\u2013based educational course, supplemented by adjunctive support messages. The primary outcome was fatigue, measured using the Functional Assessment of Chronic Illness Therapy\u2014Fatigue (FACIT-F), and the secondary outcome was self-efficacy, measured using the 13-item Inflammatory Bowel Disease Self-Efficacy Scale Short Form (IBD-SES13). A sample size of 175 participants per group was required.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Recruitment of participants began on July 28, 2025, and ended on February 24, 2026. A total of 502 patients with IBD in clinical remission agreed to participate and were assessed for eligibility. Among them, 351 met the eligibility criteria and were randomized, while 151 (30.0%) had FACIT-F scores of 40 or higher and were excluded. Currently, follow-up is ongoing. The clinical outcome data will be analyzed after follow-up is completed, and the results are expected to be submitted for publication in 2027.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study may contribute valuable knowledge regarding participant engagement and the potential impact of a multicomponent mobile cognitive behavioral intervention package on fatigue in patients with IBD. The findings will support future refinement of the intervention and inform large-scale evaluations and implementation efforts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/96593","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:01:20Z","timestamp":1790607680000},"page":"e96593-e96593","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of a Mental Health Care App\u2013Based Fatigue Management Program for Patients With Inflammatory Bowel Disease in Remission: Protocol for a Randomized Controlled Trial"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1826-3111","authenticated-orcid":false,"given":"Makoto","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2689-7399","authenticated-orcid":false,"given":"Sayaka","family":"Wakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8485-3336","authenticated-orcid":false,"given":"Kayoko","family":"Sakagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0903-9537","authenticated-orcid":false,"given":"Aki","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3094-0573","authenticated-orcid":false,"given":"Hikari","family":"N Takashina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2922-8890","authenticated-orcid":false,"given":"Jeongae","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5323-7058","authenticated-orcid":false,"given":"Masakazu","family":"Nagahori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8503-141X","authenticated-orcid":false,"given":"Hiroaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"issue":"Suppl 3","key":"R1","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","journal-title":"Gut"},{"issue":"6","key":"R2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00535-021-01784-1","article-title":"Evidence-based clinical practice guidelines for inflammatory bowel disease 2020","volume":"56","author":"Nakase","journal-title":"J Gastroenterol"},{"issue":"6","key":"R3","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.14309\/ajg.0000000000003465","article-title":"ACG clinical guideline: management of Crohn's disease in adults","volume":"120","author":"Lichtenstein","journal-title":"Am J Gastroenterol"},{"issue":"10114","key":"R4","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","journal-title":"Lancet"},{"issue":"1","key":"R5","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-024-02247-w","article-title":"Influence of multidisciplinary team care with abundant nurse staffing on patient-reported outcomes among patients with inflammatory bowel disease in clinical remission","volume":"22","author":"Tanaka","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"R6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/ibd\/izae119","article-title":"Residual disease burden among European patients with inflammatory bowel disease: a real-world survey","volume":"31","author":"Burisch","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"R7","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59030532","article-title":"Fatigue is associated with anxiety and lower health-related quality of life in patients with inflammatory bowel disease in remission","volume":"59","author":"Stroie","journal-title":"Medicina (Kaunas)"},{"issue":"5","key":"R8","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.cgh.2021.06.034","article-title":"Prevalence and risk factors for fatigue in adults with inflammatory bowel disease: a systematic review with meta-analysis","volume":"20","author":"D\u2019Silva","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"R9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41575-018-0091-9","article-title":"Fatigue in IBD: epidemiology, pathophysiology and management","volume":"16","author":"Borren","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"R10","doi-asserted-by":"publisher","first-page":"372","DOI":"10.5217\/ir.2024.00145","article-title":"Understanding fatigue among Japanese patients with inflammatory bowel disease: insights from international comparisons and meta-analysis","volume":"23","author":"Tanaka","journal-title":"Intest Res"},{"issue":"3","key":"R11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/ecco-jcc\/jjw164","article-title":"Identification of research priorities for inflammatory bowel disease nursing in Europe: a Nurses-European Crohn\u2019s and Colitis Organisation Delphi Survey","volume":"11","author":"Dibley","journal-title":"J Crohns Colitis"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctcp.2020.101229","article-title":"Non-pharmacological interventions to manage fatigue in adults with inflammatory bowel disease: a systematic review and meta-analysis","volume":"41","author":"Davis","journal-title":"Complement Ther Clin Pract"},{"issue":"13","key":"R13","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.3748\/wjg.v20.i13.3663","article-title":"Psychosocial issues in evidence-based guidelines on inflammatory bowel diseases: a review","volume":"20","author":"H\u00e4user","journal-title":"World J Gastroenterol"},{"issue":"1","key":"R14","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05466-4","article-title":"Supported online self-management versus care as usual for symptoms of fatigue, pain and urgency\/incontinence in adults with inflammatory bowel disease (IBD-BOOST): study protocol for a randomised controlled trial","volume":"22","author":"Norton","journal-title":"Trials"},{"issue":"10","key":"R15","doi-asserted-by":"publisher","first-page":"100906","DOI":"10.1016\/j.landig.2025.100906","article-title":"Digital cognitive behavioural self-management programme for fatigue, pain, and faecal incontinence in inflammatory bowel disease (IBD-BOOST): a multicentre, parallel, randomised controlled trial","volume":"7","author":"Moss-Morris","journal-title":"Lancet Digit Health"},{"issue":"4","key":"R16","doi-asserted-by":"publisher","DOI":"10.1111\/bjhp.70035","article-title":"Process evaluation findings contradict RCT results of the IBD-BOOST digital self-management intervention for fatigue, pain and faecal urgency in inflammatory bowel disease: a mixed methods study of patient perspectives","volume":"30","author":"Czuber-Dochan","journal-title":"Br J Health Psychol"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.2196\/39331","article-title":"A new digital health program for patients with inflammatory bowel disease: preliminary program evaluation","volume":"7","author":"Oddsson","journal-title":"JMIR Form Res"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081477","article-title":"SPIRIT 2025 statement: updated guideline for protocols of randomised trials","volume":"389","author":"Chan","journal-title":"BMJ"},{"issue":"4 Pt 2","key":"R19","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0016-5085(79)90384-6","article-title":"Rederived values of the eight coefficients of the Crohn\u2019s Disease Activity Index (CDAI)","volume":"77","author":"Best","journal-title":"Gastroenterology"},{"issue":"3","key":"R20","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn\u2019s disease activity index: National Cooperative Crohn\u2019s Disease Study","volume":"70","author":"Best","journal-title":"Gastroenterology"},{"issue":"12","key":"R21","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1002\/ibd.20520","article-title":"Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis","volume":"14","author":"Lewis","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"R22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001027.pub2","article-title":"Cognitive behaviour therapy for chronic fatigue syndrome in adults","volume":"2008","author":"Price","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"R23","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1037\/a0012825","article-title":"Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients","volume":"134","author":"Kangas","journal-title":"Psychol Bull"},{"key":"R24","unstructured":"FACIT-F functional assessment of chronic illness therapy\u2014fatigue. FACIT.org. URL: https:\/\/www.facit.org\/measures\/facit-f [Accessed 15-03-2024]"},{"issue":"3","key":"R25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-o","article-title":"The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue","volume":"39","author":"Smets","journal-title":"J Psychosom Res"},{"issue":"11-12","key":"R26","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1111\/j.1365-2036.2011.04871.x","article-title":"Validation of the functional assessment of chronic illness therapy-fatigue (FACIT-F) in patients with inflammatory bowel disease","volume":"34","author":"Tinsley","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"R27","first-page":"811","volume":"32","author":"Cella","journal-title":"J Rheumatol"},{"issue":"6","key":"R28","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/s0885-3924(02)00529-8","article-title":"Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales","volume":"24","author":"Cella","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"R29","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-024-03206-x","article-title":"Development and validation of a 13-item short version of the inflammatory bowel disease self-efficacy scale","volume":"24","author":"Tanaka","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"R30","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice","volume":"30","author":"White","journal-title":"Stat Med"},{"issue":"3","key":"R31","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2307\/2533558","article-title":"Small sample inference for fixed effects from restricted maximum likelihood","volume":"53","author":"Kenward","journal-title":"Biometrics"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:01:22Z","timestamp":1790607682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e96593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":31,"URL":"https:\/\/doi.org\/10.2196\/96593","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"article-number":"v15iSuppl 3e96593"}}